Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

US Patent 4910206 · Granted Mar 20, 1990

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of the (R) isomer of 2-[(2-octa-decyloxymethyl-tetrahydro-2-furanylmethoxy)-1994
Heterocyclic phospholipids useful in treating multiple sclerosis1994
Process for the preparation of the (R) stereoisomer of the monobutyric ester of 1993
Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymet1993
Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclero1993
5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno pyridines1992
Use of the R-(+)-isomer of 2-methoxy-3-octadecyloxy-propanol-(1)-phosphoric acid1992
Heterocyclic phospholipids useful in treating multiple sclerosis1991
Triglyceride-water emulsion pharmaceutical vehicles1991
5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines1991
2- or 4-substituted-[2-(1H-imidazol-1-yl)ethyl]piperidines1990
6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines1990